Form 4 for IDXX Idexx Laboratories
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0000874716-23-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-15 | 2023-05-11 | IDXX | ESSIG STUART | Dir | M - OptEx | $0.00 | +344 | 1,717 | +25% | $0 |
| D | 2023-05-15 | 2023-05-11 | IDXX | ESSIG STUART | Dir | M - OptEx | — | -344 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | M | A | 344 | $0.00 | 1,717 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2023-05-11 | M | D | 344 | — | 0 | D | — · — to — | 344 Common Stock | (F2) Not applicable. (F1) Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event was earlier. |